Amaglo NK, Bennett RN, Curto RBL, Rosa EA, Turco VL, Giuffrida A, Timpo GM
plantarum : Lactiplantibacillus plantarum References Ahmed SK, Hussein S, Qurbani K, Ibrahim RH, Fareeq A, Mahmood KA, et al
Conclusions The therapeutic scope of GLP-1R agonists is expanding beyond traditional metabolic targets, highlighting its potential for headache and pain disorders
Cohort studies indicate that patients with TBI who undergo acupuncture treatment experience a lower risk of dementia (Juan et al., 2019), stroke (Shih et al., 2014), and consciousness disorders (Lin et al., 2023), along with fewer emergency and hospital visits (Shih et al., 2013), compared to those who do not receive acupuncture
Therefore, GLP-1 analogs can benefit other conditions besides traditional diabetes and obesity uses